Related references
Note: Only part of the references are listed.Pharmacology and physiological function of the orphan GPRC6A receptor
Christinna V. Jorgensen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice
Kelsey A. Carpenter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
The Effects of Sclerostin on the Immune System
Cristine Donham et al.
CURRENT OSTEOPOROSIS REPORTS (2020)
An osteocalcin-deficient mouse strain without endocrine abnormalities
Cassandra R. Diegel et al.
PLOS GENETICS (2020)
Osteocalcin is necessary for the alignment of apatite crystallites, but not glucose metabolism, testosterone synthesis, or muscle mass
Takeshi Moriishi et al.
PLOS GENETICS (2020)
Osteocalcin promotes bone mineralization but is not a hormone
Stavros C. Manolagas
PLOS GENETICS (2020)
Bone Regulation of Insulin Secretion and Glucose Homeostasis
Patricia Ducy
ENDOCRINOLOGY (2020)
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture
James R. Turk et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
Jonas Bovijn et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Humanized GPRC6AKGKY is a gain-of-function polymorphism in mice
Min Pi et al.
SCIENTIFIC REPORTS (2020)
The facts of the matter: What is a hormone?
Gerard Karsenty
PLOS GENETICS (2020)
Lack of reproducibility in osteocalcin-deficient mice
Takeshi Moriishi et al.
PLOS GENETICS (2020)
Independent validation of experimental results requires timely and unrestricted access to animal models and reagents
Cassandra R. Diegel et al.
PLoS Genetics (2020)
Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!
Vincent M. Brandenburg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes
Matthias von Herrath et al.
CELL METABOLISM (2019)
Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism
Soohyun P. Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Novel actions of sclerostin on bone
Gill Holdsworth et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2019)
Sclerostin Antibody Mitigates Estrogen Deficiency-Inducted Marrow Lipid Accumulation Assessed by Proton MR Spectroscopy
Shaojun Li et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Inverse correlation between trabecular bone volume and bone marrow adipose tissue in rats treated with osteoanabolic agents
Samantha Costa et al.
BONE (2019)
Mediation of the Acute Stress Response by the Skeleton
Julian Meyer Berger et al.
CELL METABOLISM (2019)
Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures
Jie Zheng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Osteocalcin affects bone mineral and mechanical properties in female mice
O. Berezovska et al.
BONE (2019)
Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease
Annelies De Mare et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis
Heather Fairfield et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development
Cristal S. Yee et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Osteocalcin in the brain: from embryonic development to age-related decline in cognition
Arnaud Obri et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Circulating levels of sclerostin are associated with cardiovascular mortality
Cristina Novo-Rodriguez et al.
PLOS ONE (2018)
Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300
Takahito Otani et al.
CELL DEATH & DISEASE (2018)
RbAp48 Protein Is a Critical Component of GPR158/OCN Signaling and Ameliorates Age-Related Memory Loss
Stylianos Kosmidis et al.
CELL REPORTS (2018)
Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease
Cong Zeng et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Phosphate Homeostasis, Inflammation and the Regulation of FGF-23
Florian Lang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis
Smriti Murali Krishna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial
Francis H. Glorieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots
Keertik Fulzele et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia
Lothar Seefried et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Gpr158 mediates osteocalcin's regulation of cognition
Lori Khrimian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease
Fabiana G. Graciolli et al.
KIDNEY INTERNATIONAL (2017)
MC4R-dependent suppression of appetite by bone-derived lipocalin 2
Ioanna Mosialou et al.
NATURE (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
Soohyun P. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
UPDATE ON THE BIOLOGY OF OSTEOCALCIN
Gerard Karsenty
ENDOCRINE PRACTICE (2017)
Osteocalcin and its endocrine functions
Akiko Mizokami et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Sclerostin deficiency in humans
Antoon H. van Lierop et al.
BONE (2017)
Sclerostin expression and functions beyond the osteocyte
Megan M. Weivoda et al.
BONE (2017)
Hormonal and systemic regulation of sclerostin
Matthew T. Drake et al.
BONE (2017)
Role and mechanism of action of sclerostin in bone
Jesus Delgado-Calle et al.
BONE (2017)
Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance
Josep Puig et al.
CLINICAL ENDOCRINOLOGY (2016)
Association between osteocalcin and cognitive performance in healthy older adults
Steven Bradburn et al.
AGE AND AGEING (2016)
The systemic effects of sclerostin overexpression using ΦC31 integrase in mice
Dongdong Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model
Cristal S. Yee et al.
BONE (2016)
Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication
Gerard Karsenty et al.
CELL (2016)
Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise
Paula Mera et al.
CELL METABOLISM (2016)
Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9 technology
Laura J. Lambert et al.
DISEASE MODELS & MECHANISMS (2016)
Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells
Mayumi Ukita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?
C. B. Confavreux et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Osteocalcin is necessary and sufficient to maintain muscle mass in older mice
Paula Mera et al.
MOLECULAR METABOLISM (2016)
From disease to treatment: from rare skeletal disorders to treatments for osteoporosis
Natasha M. Appelman-Dijkstra et al.
ENDOCRINE (2016)
LRP5 Regulates Human Body Fat Distribution by Modulating Adipose Progenitor Biology in a Dose- and Depot-Specific Fashion
Nellie Y. Loh et al.
CELL METABOLISM (2015)
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism
Giuseppe Daniele et al.
DIABETES CARE (2015)
Methylation of Bone SOST, Its mRNA, and Serum Sclerostin Levels Correlate Strongly With Fracture Risk in Postmenopausal Women
Sjur Reppe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Abdul Rashid Qureshi et al.
KIDNEY INTERNATIONAL (2015)
Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
Ritambhara Singh et al.
NUCLEIC ACIDS RESEARCH (2015)
Quantifying on- and off-target genome editing
Ayal Hendel et al.
TRENDS IN BIOTECHNOLOGY (2015)
Regulation of energy metabolism by the skeleton: Osteocalcin and beyond
Mathieu Ferron et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans
Matthew M. Roforth et al.
BONE (2014)
Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a
Jianwen Wei et al.
DIABETES (2014)
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Seung Woo Cho et al.
GENOME RESEARCH (2014)
Carboxylated and Uncarboxylated Forms of Osteocalcin Directly Modulate the Glucose Transport System and Infl ammation in Adipocytes
H. S. Hill et al.
HORMONE AND METABOLIC RESEARCH (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Circulating Sclerostin Associated With Vertebral Bone Marrow Fat in Older Men But Not Women
Yu-Heng Vivian Ma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Reduced Renal Calcium Excretion in the Absence of Sclerostin Expression: Evidence for a Novel Calcium-Regulating Bone Kidney Axis
Rajiv Kumar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
Yifu Fang et al.
KIDNEY INTERNATIONAL (2014)
E-CRISP: fast CRISPR target site identification
Florian Heigwer et al.
NATURE METHODS (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Ming-Kang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
X-ray Crystal Structure of Bovine 3 Glu-Osteocalcin
Vladimir N. Malashkevich et al.
BIOCHEMISTRY (2013)
Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions
Franck Oury et al.
CELL (2013)
Adiponectin Regulates Bone Mass via Opposite Central and Peripheral Mechanisms through FoxO1
Daisuke Kajimura et al.
CELL METABOLISM (2013)
The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD
Solenne Pelletier et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The Osteocyte: An Endocrine Cell . . . and More
Sarah L. Dallas et al.
ENDOCRINE REVIEWS (2013)
Osteocalcin Reverses Endoplasmic Reticulum Stress and Improves Impaired Insulin Sensitivity Secondary to Diet-Induced Obesity Through Nuclear Factor-κB Signaling Pathway
Bo Zhou et al.
ENDOCRINOLOGY (2013)
Sclerostin: Another Vascular Calcification Inhibitor?
Kathleen J. Claes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis
Franck Oury et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu et al.
NATURE BIOTECHNOLOGY (2013)
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Vikram Pattanayak et al.
NATURE BIOTECHNOLOGY (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch
Jiqiu Wang et al.
NATURE CELL BIOLOGY (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium
Zachary C. Ryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Novel Bone Endocrine Networks Integrating Mineral and Energy Metabolism
Min Pi et al.
CURRENT OSTEOPOROSIS REPORTS (2013)
Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice
Mathieu Ferron et al.
BONE (2012)
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Jun Wu et al.
CELL (2012)
Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus
A. H. van Lierop et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Yves Sabbagh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Association of Circulating Sclerostin Levels with Fat Mass and Metabolic Disease-Related Markers in Japanese Postmenopausal Women
Tomohiko Urano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Bente K. Pedersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Endocrine Regulation of Male Fertility by the Skeleton
Franck Oury et al.
CELL (2011)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Single-Dose, Placebo-Controlled, Randomized Study of AMG 785, a Sclerostin Monoclonal Antibody
Desmond Padhi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
GPRC6A Mediates Responses to Osteocalcin in β-Cells In Vitro and Pancreas In Vivo
Min Pi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Patients With Sclerosteosis and Disease Carriers: Human Models of the Effect of Sclerostin on Bone Turnover
Antoon H. van Lierop et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Determinants of Serum Sclerostin in Healthy Pre- and Postmenopausal Women
Mohammed-Salleh M. Ardawi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Amazing Osteocyte
Lynda F. Bonewald
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Determination of Serum and Plasma Sclerostin Concentrations by Enzyme-Linked Immunoassays
Melissa McNulty et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima et al.
NATURE MEDICINE (2011)
The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
Dongxing Zhu et al.
PLOS ONE (2011)
Regulation of gene expression in osteoblasts
Eric D. Jensen et al.
BIOFACTORS (2010)
Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition
Keertik Fulzele et al.
CELL (2010)
Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism
Mathieu Ferron et al.
CELL (2010)
Cthrc1 Is a Positive Regulator of Osteoblastic Bone Formation
Hiroaki Kimura et al.
PLOS ONE (2008)
GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome
Min Pi et al.
PLOS ONE (2008)
Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice
Mathieu Ferron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
Larry Pederson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
LRP6 mutation in a family with early coronary disease and metabolic risk factors
Arya Mani et al.
SCIENCE (2007)
Evidence that the mouse osteocalcin-related gene does not encode nephrocalcin
Martin Petrucci et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2006)
Parathyroid hormone: past and present
JT Potts
JOURNAL OF ENDOCRINOLOGY (2005)
Bone mineral density in sclerosteosis;: Affected individuals and gene carriers
JC Gardner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
KES Poole et al.
FASEB JOURNAL (2005)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Bone recognition mechanism of porcine osteocalcin from crystal structure
QQ Hoang et al.
NATURE (2003)
The natural history of sclerosteosis
H Hamersma et al.
CLINICAL GENETICS (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T Yamauchi et al.
NATURE MEDICINE (2001)
Inhibition of adipogenesis by Wnt signaling
SE Ross et al.
SCIENCE (2000)
Share Paper
